MYC and cancer: ITH of seven meta-programs, related to cell cycle, stress, hypoxia, interferon responses, EMT, and MYC targets, was frequent in most cancer types, 21 meta-programs were shared only between a subset of cancer types, and the variability of the remaining meta-programs was tumor-type specific [90].